Me Today Limited/Announcement
Me Today Limited logo

Me Today results for the six months ended 31 December 2022

Half Year Results28 February 2023MEEConsumer Staples

1


1 March 2023


Me Today results for the six months ended 31 December 2022

Me Today Limited (NZX: MEE) has released its unaudited Group results for the six months ended 31

December 2022.

The result for the Group records net revenue of $3.60m compared to $3.66 for the six months ended

31 December 2021. The Group incurred a loss after tax of $5.81m in the period compared to $3.91m

in the six months ended 31 December 2021. The operating EBITDA loss for the period is $3.08m

before adjusting for the estimated loss on the current season’s harvest. Further explanation of the

result is included below with a reconciliation of the items between operating EBITDA and the net

loss after tax.

Gross revenue for the Group before the costs of marketing services provided by a customer was

$4.15m. This was split between the Honey segment of $2.51m, Me Today branded sales of $1.35m

and agency services revenue at $0.28m.

As advised previously the company received orders of $1.6m in respect to its BEE+ brand that will

ship in the first quarter of the 2023 calendar year. As a result, the sales for the second half of the

financial year will be higher than the first half and the operating loss will be lower.

The Group has now fully implemented the restructuring of the Beekeeping Division and has

consolidated its manufacturing site in Taupō. As described further below the Group continues to

create sales opportunities across its three core brands. The sales activity comes from new customers

and repeat business building with existing customers. With borders now opening post Covid the

Group is seeing increased activity internationally. In particular there is increased interest in China for

Mānuka honey, which we are seeing both domestically in NZ and in market in China. The Group

believes this will continue to build as the Duty-Free channel in New Zealand opens fully to Chinese

Tourists.


Taking into account the current sales pipeline, the Group believes it has sufficient funding to meet

operational requirements while it focusses on continuing to grow the business.

As discussed in December in terms of brands, we now have 3 focus brands, Me Today, SuperLife and

BEE+.


BEE +

The largest immediate opportunity the Group continues to have is with Bee+ through Access

Corporate Group (ACG) and its brand management division Access Brand Management (ABM). ABM

and the Me Today Group jointly own the Bee+ Mānuka honey brand.


Management have built a close working relationship with ABM and meet on a regular basis to

discuss the requirements of the BEE+ Brand.


The opening of borders internationally and within China continue to benefit trading in the BEE+

brand and discussions are ongoing with ABM in respect to purchase orders for the 2023 calendar

year.


2


Me Today Brand

With Me Today we continue to invest in establishing the brand locally in New Zealand and

Internationally.


In New Zealand the brand continues to have a strong presence in pharmacy and grocery stores

nationally. The trading model in the latest six months has changed as compared to the December

2021 period with further investment into the retail partnership meaning a decrease in New Zealand

net revenue as a result of the accounting treatment of marketing spend which is deducted from

gross revenue.


In Ireland Me Today continues to be listed in approximately 200 retail stores across independent

pharmacies, Chemist Warehouse and Tesco. The focus within the Irish market is in building the

relationship with Tesco and Chemist Warehouse. In the six months to 31 December 2022, sales in

Ireland were $158k versus $433k in the comparative six month period. The sales in the December

2021 period included pipefill in stocking the Irish distributor.


The Group is reviewing its strategy of investment for Me Today in international markets to limit

spreading its resources too widely. Outside of NZ and the Irish market investment in brand will be

limited to the US, Japan, UAE and Australia. Each market is reviewed continuously to ensure brand

growth is achieved.


SuperLife


SuperLife provides the Group with a Mānuka honey brand that competes in different parts of the

market to both Me Today and BEE+.


As we have advised previously SuperLife has customer and distributor relationships across a number

of international markets. The opportunities within these markets continue to change as the sell

through rate of products is established.


The largest opportunity for SuperLife currently is the relationship with a US grocery chain. Initial sell

through has been positive and a full calendar year forecast has been received. Sales to the customer

are expected to be greater than NZD $1m for the 2023 calendar year. Discussions on how to expand

out the range are taking place with this retailer.


Outside of NZ and the USA, the focus markets for SuperLife are Germany, Romania and the UAE with

sales and reorders into these markets over the past six months.


Investment into the SuperLife brand and International markets will focus around markets where

ongoing sell through of product is being established.



Beekeeping Operations


The Group’s restructured beekeeping operation now has 4,000 hives in the North Island with two

branches operating out of Turangi and Masterton. The industry over the past few years has had a

surplus of Mānuka honey resulting from seasons of strong production and lower demand driven by

Covid. The 2023 season has been significantly impacted by the weather and industry wide

indications are that the season production will be well below average. The 2023 season honey is

currently being harvested, volumes and quality are currently unknown. The Group however expects


3


that the wholesale value of honey for the 2023 season at harvest date will be less than cost requiring

a write down in the year ending 30 June 2023. The exact amount of the write down will not be

known until all testing and processing has been completed. A decision however has been taken to

write down the expected value of the harvest by $0.86m in this period.


The key aspects of the Group’s consolidated financial statements for the six months to

31 December 2022 are explained further below:


• The operating EBITDA loss for the Group was $3.08m, split between the business divisions as

follows.

o The Me Today sale of goods and agency services segment operating EBITDA loss was

$1.33m compared to an EBITDA loss of $1.06m for the 6 months ended 31

December 2021.

o The King Honey segment operating EBITDA loss (before adjusting for the estimated

loss on the current season’s harvest) was $1.06m which was consistent with the six

months to 31 December 2021.

o The listed company and shared services operating costs were $0.69m compared to

$0.63m for the 6 months ended 31 December 2021.

Deducted from operating EBITDA were expenses amounting to $2.73m resulting in a net loss after

tax of $5.81m.

The $2.73m of expenses consisted of the following.


• Write down of the 2023 season harvest $0.86m

• Finance Costs (net) $0.29m

• Fair Value loss on Biological Assets $0.54m

• Depreciation and Amortisation $0.25m

• Amortisation of customer relationship asset $0.54m

• Restructuring costs $0.15m

• Write Down of Assets held for sale $0.10m


Total Expenses deducted from EBITDA $2.73m

Further explanation of these are provided below.


o Write down of the current season Harvest

As explained above the Group has taken the decision to write down the value of the

current season harvest by $0.86m due to the impact of the weather on the harvest.

Full details of the harvest will not be known until all processing and testing is

complete later in this financial year.

o Amortisation of the Customer Relationship Asset

The Group completed a valuation of intangibles acquired at acquisition. The ABM

contract was separately identified and has been valued at $9.3m at acquisition date.

The Group has determined 8 years as the appropriate useful life for this asset


4


resulting in an annual amortisation charge of $1.08m. Half of this amount of $542k

has been included in these consolidated financial statements.

o Closure of beekeeping branches and Consolidation of the Taupō Production Facility

The following costs have been incurred as a result of the decision to close the three

beekeeping branches and the consolidation of the Taupō Production Facility.

• The ongoing reduction in hive numbers has resulted in a biological asset fair

value loss of $0.54m.

• Property, plant and equipment and biological assets with a combined

carrying value of $0.52m have been identified as assets held for sale. These

have been assessed at fair value resulting in a write down of $0.10m.

$0.128m remain unsold as at 31 December 2022.

• Restructuring costs of $0.15m have been incurred in relation to closing

beekeeping branches and consolidating the Taupō Production Facility.

For further information, please contact:


Grant Baker

Chairman, Me Today Limited

021 729 800



Michael Kerr

Chief Executive Officer, Me Today Limited

021 836 451

michael@metoday.com

---

Unaudited results announcement for the 6 months ended 31 December 2022

Results for announcement to the market

Name of issuer Me Today Limited

Reporting Period 6 months to 31 December 2022

Previous Reporting Period 6 months to 31 December 2021

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$3,599 (2)%

Total Revenue $3,599 (2)%

Net profit/(loss) from

continuing operations

$(5,805) 49%

Total net profit/(loss) $(5,805) 49%

Interim/Final Dividend

Amount per Quoted Equity

Security

The Company does not propose to pay a dividend at this time

Imputed amount per Quoted

Equity Security

Not applicable

Record Date Not applicable

Dividend Payment Date Not applicable

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security

As at December 2022:

$0.0079

As at June 2022:

$0.0114

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Refer to the unaudited financial statements and press release

that accompany this announcement.

Authority for this announcement

Name of person


authorised

to make this announcement

Stephen Sinclair

Contact person for this

announcement

Stephen Sinclair

Contact phone number 021 330 053

Contact email address stephen@metoday.com

Date of release through MAP


1

st

March 2023


Unaudited financial statements accompany this announcement.

---

Me Today Limited


Unaudited Condensed Interim

Consolidated Financial Statements



For the six months ended 31 December 2022








Me Today Limited
Unaudited Condensed Interim Consolidated Financial Statements

For the six months ended 31 December 2022




2

Contents



Page

Consolidated Statement of Profit or Loss and other Comprehensive

Income

3

Consolidated Statement of Changes in Equity 4

Consolidated Statement of Financial Position 5

Consolidated Statement of Cash Flows 6

Condensed Notes to the Interim Consolidated Financial Statements 7

Company Directory 17


Me Today Limited
Consolidated Statement of Profit or Loss and other Comprehensive

Income

For the six months ended 31 December 2022





These interim financial statements have not been audited, nor reviewed by the auditor. The accompanying notes form

part of these interim financial statements and should be read in conjunction with them.

3



6 mths ended

6 mths ended

31 Dec 2022

31 Dec 2021

Note

(unaudited)

(unaudited)

NZ$000

NZ$000

Revenue before marketing services provided by a customer

4,146

3,942

Less marketing services provided by a customer

(547)

(286)

Revenue

4

3,599

3,656

Cost of sales

(2,178)

(2,379)

Selling and marketing expenses

(1,651)

(1,694)

Distribution expenses

(437)

(240)

Administrative and other operating expenses

(2,657)

(2,390)

Amortisation of customer relationship asset

(542)

(542)

Impairment of biological work in progress asset

11

(861)

-

Finance income

4

4

Finance expenses

5

(289)

(275)

Acquisition related costs

-

(45)

Operating loss before restructure related items and

income tax

5

(5,012)

(3,905)

Fair value loss on biological assets

10

(544)

-

Restructuring costs

(151)

-

Write down of assets held for sale

8

(98)

-

Loss before income tax

(5,805)

(3,905)

Income tax (expense)/benefit

-

-

Loss for the period attributable to owners of the company

(5,805)

(3,905)

Other comprehensive income

Other comprehensive income for the period

-

-

Total comprehensive loss for the period attributable to

owners of the company

(5,805)

(3,905)

Earnings (loss) per share:

Basic and diluted loss per share (NZ$)

7

(0.0038)

(0.0055)

Me Today Limited
Consolidated Statement of Changes in Equity

For the six months ended 31 December 2022





These interim financial statements have not been audited, nor reviewed by the auditor. The accompanying notes form

part of these interim financial statements and should be read in conjunction with them.

4


Share

Share

based

payments

Accumulated

Total

capital

reserve

losses

equity

NZ$000

NZ$000

NZ$000

NZ$000

At 1 July 2021 (unaudited)

38,744

33

(17,421)

21,356

Total comprehensive income

Loss attributable to owners of the company

-

-

(3,905)

(3,905)

Transactions with owners

Share options issued

-

12

-

12

Other share based payments

-

56

-

56

At 31 December 2021 (unaudited)

38,744

101

(21,326)

17,519

At 1 July 2022 (audited)

51,427

77

(27,405)

24,099

Total comprehensive income

Loss attributable to owners of the company

-

-

(5,805)

(5,805)

Transactions with owners

Shares issued during the period

752

-

-

752

Less: share issue costs

(70)

-

-

(70)

Share options issued

-

3

-

3

Other share based payments

-

61

-

61

At 31 December 2022 (unaudited)

52,109

141

(33,210)

19,040

Me Today Limited
Consolidated Statement of Financial Position

As at 31 December 2022



These interim financial statements have not been audited, nor reviewed by the auditor. The accompanying notes form

part of these interim financial statements and should be read in conjunction with them.

5



These financial statements were approved by the Board on 28 February 2023.

Signed on behalf of the Board by:



Grant Baker Michael Kerr

31 Dec 202230 Jun 2022

Note(unaudited)(audited)

NZ$000NZ$000

ASSETS

Current assets

Cash and cash equivalents2,3125,370

Trade and other receivables82,8531,199

Inventory15,64816,793

Biological work in progress111,171698

Taxation receivable935

21,99324,095

Assets classified as held for sale91281,063

Total current assets22,12125,158

Non-current assets

Biological assets107521,598

Property, plant and equipment3,2803,788

Right-of-use assets12.18011,387

Customer relationship asset6,8947,436

Other intangible assets9689

Total non-current assets11,82314,298

Total assets33,94439,456

LIABILITIES

Current liabilities

Trade and other payables1,7881,766

Lease liabilities12.2281316

Borrowings13538942

Total current liabilities2,6073,024

Non-current liabilities

Lease liabilities12.25011,041

Borrowings1311,79611,292

Total non-current liabilities12,29712,333

Total liabilities14,90415,357

Net assets

19,04024,099

EQUITY

Share capital52,10951,427

Share based payments reserve14177

Accumulated losses(33,210)(27,405)

Total equity

19,04024,099

Me Today Limited
Consolidated Statement of Cash Flows

For the six months ended 31 December 2022




These interim financial statements have not been audited, nor reviewed by the auditor. The accompanying notes form

part of these interim financial statements and should be read in conjunction with them.

6


6 mths ended

6 mths ended

31 Dec 2022

31 Dec 2021

Note

(unaudited)

(unaudited)

NZ$000

NZ$000

Cash flows from operating activities

Receipts from customers

2,707

3,130

Payments to suppliers and employees

(7,377)

(9,175)

Interest received

4

4

Income tax (paid)/refunded

26

(4)

Net cash used in operating activities

15

(4,640)

(6,045)

Cash flows from investing activities

Acquisition related costs

-

(45)

Payments for property, plant and equipment

(15)

(208)

Payments for intangibles

(8)

(10)

Proceeds from sale of assets held for sale

1,360

-

Net cash from/(used in) investing activities

1,337

(263)

Cash flows from financing activities

Proceeds from issue of share capital

753

-

Share capital issue costs

(70)

-

Repayment of principal on borrowings

-

(797)

Interest paid on borrowings

(177)

(159)

Payment of lease liabilities

(242)

(670)

Interest paid on lease liabilities

(19)

(43)

Net cash flows from/(used in) financing activities

245

(1,669)

Net decrease in cash and cash equivalents

(3,058)

(7,977)

Cash and cash equivalents at 1 July

5,370

6,576

Cash and cash equivalents at 31 December

2,312

(1,401)

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



7

1. General information

Me Today Limited (‘the Company’) is a limited liability company incorporated and domiciled in New

Zealand.

The condensed interim consolidated financial statements presented are for Me Today Limited and its

subsidiaries (together ‘the Group’).

The Group produces, sells, and markets health and wellbeing products or acts as an agent on behalf of

other health and wellbeing suppliers. The Group also produces and sells premium Mānuka honey.

2. Basis of preparation

These unaudited condensed interim consolidated financial statements for the 6 months ended

31 December 2022 have been prepared in accordance with New Zealand Generally Accepted Accounting

Practice (‘NZ GAAP’), with New Zealand Equivalent to International Accounting Standard 34: Interim

Financial Reporting (‘NZ IAS 34’), with International Accounting Standard 34: Interim Financial Reporting

(‘IAS 34’), and with the requirements on the NZX Listing Rules.

Me Today Limited is a company registered under the Companies Act 1993 and is an FMC reporting entity

under the Financial Markets Conduct Act 2013. The Company is listed on the NZX Main Board.

The condensed interim consolidated financial statements do not include all of the notes of the type

normally included in an annual financial report. Accordingly, this report should be read in conjunction with

the financial statements included in the annual report for the year ended 30 June 2022 which have been

prepared in accordance with New Zealand equivalents to International Financial Reporting Standards (‘NZ

IFRS’) and International Financial Reporting Standards (‘IFRS’).

The condensed interim consolidated financial statements are presented in New Zealand dollars which is

the Company’s functional and presentation currency, rounded to the nearest thousand dollars.

This is the first time the Group has reported interim results for the six months to 31 December following

the recent change of balance date from 31 March to 30 June. As a result, this is also the first time the

Group has reported the financial results for the 6 months to 31 December 2021 as shown in the

comparatives. The condensed interim consolidated financial statements, including the financial results for

the 6 months to 31 December 2022 and 2021, are unaudited. The comparative information as at 30 June

2022 and for the 15 months then ended, is audited.

2.1. Basis of measurement

The condensed interim consolidated financial statements have been prepared on a historical cost basis,

except for biological assets which are measured at fair value less cost to sell. Historical cost is generally

based on the fair value of the consideration given in exchange for goods and services.

2.2. Impact of COVID-19

The international and domestic impact of the COVID-19 pandemic, including the ongoing lockdowns in

China, continued to have an impact on the Group’s performance during the period.

Retail domestic sales have continued to be impacted by the reduced number of tourists in New Zealand.

King Honey’s most important customer relationship currently is the partnership relating to the Bee+ brand.

This brand is well established in the Chinese market with an extensive reach created by the brand

principal and distribution partner. The impact of the COVID-19 pandemic in China, including lockdowns,

impacted on the volume of sales through this distribution partner. The financial impact of the downsizing of

the King Honey operations, which commenced in the previous financial period, is linked to this

underperformance of Bee+ distribution in the Chinese market.

The COVID-19 pandemic has not had a material impact on trade receivables.

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



8

2.3. Going concern

The interim consolidated financial statements have been prepared on a going concern basis, which

assumes that the Group has the intention and ability to continue its operations for the foreseeable future.

The Group incurred an after-tax loss of $5.8 million in the 6 months to 31 December 2022 (6 months to

31 December 2021: $3.9 million loss). The Group’s net cash outflows from operating activities during the 6

months was $4.6 million (2021: $6.0 million net cash outflow).

At the reporting date the Group had cash of $2.31 million (30 June 2022: $5.37 million), working capital of

$19.5 million (30 June 2022: $22.1 million) and net assets of $19.0 million (30 June 2022: $24.1 million).

The Group had bank loans of $7.03 million (30 June 2022: $7.03 million), and a subordinated note

payable of $5.3 million (30 June 2022: $5.2 million) which is due for payment to the previous owners of

King Honey in June 2024.

The considered view of the Board is that, after making due enquiries and considering relevant factors,

there is a reasonable expectation that the Group will have access to adequate resources and

commitments from its borrowers, that will enable it to meet its financial obligations for the foreseeable

future.

For this reason, the Board considers the adoption of the going concern basis in preparing the unaudited

interim consolidated financial statements for the 6 months ended 31 December 2022 to be appropriate.

The Board has reached this conclusion having regard to circumstances which it considers likely to affect

the Group during the period of at least one year from the date of approval of these interim consolidated

financial statements, and to circumstances which it considers will occur after that date which will affect the

validity of the going concern basis.

The Directors are satisfied, based on their review of the Group’s current financial forecasts, that, during

the 12 months after the date of signing these condensed interim consolidated financial statements, there

will be adequate cash flows available to meet the financial obligations of the Group as they arise. This

consideration is made with reference to the following events:

The Group’s banker, Bank of New Zealand, has confirmed that it will keep the Group’s existing bank

facilities in place (refer note 13) subject to further review no later than 31 August 2023 in conjunction with

the FY23 audited financial statements and FY24 budget. Facilities will remain on an interest only basis

until 31 August 2023. The requirement for an amortisation programme will be considered at that time in

conjunction with the FY24 budget. The bank also confirmed covenant requirements were amended to

extend the suspension of earnings-related covenants until 31 August 2023 at which stage the covenants

will be aligned with the FY24 budget.

The Group currently has available overdraft facilities of $5 million to support seasonal operating cash

flows.

Strong commercial relationships continue to be developed with new customers with ongoing expansion

into international markets.

3. Changes in Significant Accounting Policies

There have been no changes in the accounting policies and methods of computation used in preparing the

condensed interim consolidated financial statements compared to those used in preparing the audited

consolidated financial statements for the 15 months ended 30 June 2022. For details of the accounting

policies for the 15 months ended 30 June 2022 please refer to the 2022 Annual Report.

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



9

4. Revenue


The details above disaggregate the Group's revenue from contracts with customers into primary markets,

and major product and service lines.

The Group’s revenue by geographical region is shown below.


5. Expenses

The loss for the period includes the following expenses.


6 mths ended

6 mths ended

31 Dec 2022

31 Dec 2021

(unaudited)

(unaudited)

NZ$000

NZ$000

1,353

1,524

(547)

(286)

Revenue from sale of health and wellbeing products

806

1,238

Revenue from sale of honey products

2,509

2,216

Revenue from agency services

284

202

Total revenue

3,599

3,656

Revenue from sale of health and wellbeing products before marketing

services provided by customers

Less marketing services provided by customers

6 mths ended

6 mths ended

31 Dec 2022

31 Dec 2021

(unaudited)

(unaudited)

NZ$000

NZ$000

New Zealand

2,953

3,202

Europe

158

433

United Kingdom

19

21

United States

469

-

Total revenue

3,599

3,656

6 mths ended6 mths ended

31 Dec 202231 Dec 2021

(unaudited)(unaudited)

NZ$000NZ$000

Salaries(2,196)(3,194)

Employer Kiwisaver contributions(74)(74)

Directors' fees(235)(198)

Depreciation and amortisation:

Depreciation of property, plant and equipment(302)(449)

Depreciation of right of use assets(254)(458)

Amortisation of customer relationship asset(542)(542)

Amortisation of intangible assets(1)(3)

(1,099)(1,452)

Depreciation and amortisation is allocated as follows:

Capitalised to biological work in progress308642

Included in the operating loss(791)(810)

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



10



6. Segment information

The Group produces, sells, and markets health and wellbeing products (‘sale of goods’ segment) or acts

as an agent on behalf of other health and wellbeing suppliers (‘agency services’ segment). The Group

also produces and sells premium Mānuka honey (‘honey’ segment).




The Group has identified its operating segments based on the internal reports reviewed and used by the

Chief Operating Decision Maker (‘CODM’), being the Board of Directors, in assessing the Group’s

performance and in determining the allocation of resources.

Unallocated operating expenses include head office costs and costs related to the NZX listing.

Significantly all operations are carried out in New Zealand.

6.1. Seasonal and cyclical influences

The Group’s honey production operations have seasonal influences. Over winter, hives are downsized

and operating costs are primarily spent on maintaining hives and operations. Honey production occurs

from early spring to late summer with the majority of honey harvest occurring from January to March.

Operating costs increase during the honey production and harvest months. Beekeeping costs are deferred

6 mths ended

6 mths ended

31 Dec 2022

31 Dec 2021

(unaudited)

(unaudited)

NZ$000

NZ$000

Finance expenses:

Interest on lease liabilities

(19)

(43)

Interest on borrowings

(277)

(259)

(296)

(302)

Finance expenses are allocated as follows:

Capitalised to biological work in progress

7

27

Included in the operating loss

(289)

(275)

Sale of

Agency

Honey

Other /

Total

Sale of

Agency

Honey

Other /

Total

goods

services

unallocated

goods

services

unallocated

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

1,353

284

2,509

-

4,146

1,524

202

2,216

-

3,942

(547)

-

-

-

(547)

(286)

-

-

-

(286)

Total external revenue

806

284

2,509

-

3,599

1,238

202

2,216

-

3,656

Total inter-segment revenue

-

-

-

-

-

-

-

-

-

-

Operating EBITDA

(1,240)

(85)

(1,058)

(692)

(3,075)

(934)

(127)

(1,086)

(632)

(2,779)

-

-

(861)

-

(861)

-

-

-

-

-

Depreciation and amortisation

(4)

(2)

(735)

(50)

(791)

(8)

(3)

(750)

(49)

(810)

Fair value loss on biological assets

-

-

(544)

-

(544)

-

-

-

-

-

Restructuring costs

-

-

(151)

-

(151)

-

-

-

-

-

Write down of assets held for sale

-

-

(98)

-

(98)

-

-

-

-

-

Acquisition related costs

-

-

-

-

-

-

-

-

(45)

(45)

Finance income

-

-

-

4

4

-

-

-

4

4

Finance expenses

-

-

(287)

(2)

(289)

-

-

(272)

(3)

(275)

Net loss before taxation

(1,244)

(87)

(3,734)

(740)

(5,805)

(942)

(130)

(2,108)

(725)

(3,905)

Income tax expense

-

-

-

-

-

-

-

-

-

Net loss for the year

(1,244)

(87)

(3,734)

(740)

(5,805)

(942)

(130)

(2,108)

(725)

(3,905)

Sale of

Agency

Honey

Other /

Total

Sale of

Agency

Honey

Other /

Total

goods

services

unallocated

goods

services

unallocated

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

NZ$000

Segment assets

3,610

417

28,930

1,848

34,805

2,255

147

31,590

5,464

39,456

Segment liabilities

378

138

14,036

352

14,904

396

43

14,471

447

15,357

Six months ended 31 December 2022

Six months ended 31 December 2021

Revenue before marketing services

Less marketing services provided

As at 31 December 2022

As at 30 June 2022

Impairment of biological work in

progress asset

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



11

and recognised as biological work in progress (net of any impairment) up until harvest, at which point they

are transferred to inventory. Sales of honey occur throughout the year and the cost of honey sold is

recognised at the same time.

There are no seasonal or cyclical influences on the sale of goods or agency services operations.

7. Earnings per share


At 31 December 2022, there were no financial instruments that carried any shareholder dilution rights that

were considered to be dilutive (2021: none). The 1,000,000 share options on issue where not considered

to be dilutive due to the Group’s loss (2021: 2,000,000 share options).

8. Trade and other receivables


6 mths ended

6 mths ended

31 Dec 2022

31 Dec 2021

(unaudited)

(unaudited)

Basic and dilluted earnings/(loss) per share (NZ$)

(0.0038)

(0.0055)

Loss from continuing operations (NZ$000)

(5,805)

(3,905)

1,523,567

706,446

The losses and weighted average number of ordinary shares used in the calculation of loss per share are as

follows:

Weighted average number of ordinary shares used in the calculation of

basic and diluted earnings per share ('000)

31 Dec 2022

30 Jun 2022

(unaudited)

(audited)

NZ$000

NZ$000

Trade receivables

1,705

913

Other receivables

654

5

101

112

Prepayments

393

169

2,853

1,199

GST receivable

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



12

9. Assets held for sale



The Group has continued to downsize its beekeeping operations which commenced in the previous

reporting period.

10. Biological assets


The reduction in the number of hives and the resulting reduction in the fair value of the biological asset in

the six months to 31 December 2022, is a result of the downsizing of the beekeeping operations.

31 Dec 2022

31 Dec 2021

30 Jun 2022

(unaudited)

(unaudited)

(audited)

NZ$000

NZ$000

NZ$000

Opening balance

1,063



-



-



Reclassified from property, plant & equipment:

- cost

275



-



744



- accumulated depreciation

(54)



-



(104)



Write down of assets held for sale

(31)



-



(190)



Net book value reclassified from property, plant &

equipment

190



-



450



Reclassified from biological assets

302



-



965



Write down of assets held for sale

(67)



-



(352)



Net book value reclassified from biological assets

235



-



613



Sales of assets

(1,360)



-



-



At reporting date

128



-



1,063



31 Dec 202231 Dec 202130 Jun 2022

(unaudited)(unaudited)(audited)

NZ$000NZ$000NZ$000

Bees:

Opening balance1,598 3,283 -

Acquisition of subsidiaries- - 3,283

Reclassified to assets held for sale(302)- (965)

Fair value loss on biological assets(544) - (720)

At reporting date752 3,283 1,598

31 Dec 202231 Dec 202130 Jun 2022

number ofnumber ofnumber of

Operational hives:

Opening balance8,950 18,394 -

Acquisition of subsidiaries- - 15,595

Net movement in operational hives(4,738) - (6,645)

At reporting date4,212 18,394 8,950

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



13

11. Biological work in progress


The impairment loss recognised reduces the carrying value of biological work in progress to its estimated

realisable value.

12. Leases

12.1. Right-of-use asset

The Group leases warehouse and administration premises, and land used for hive placements.



31 Dec 2022

31 Dec 2021

30 Jun 2022

(unaudited)

(unaudited)

(audited)

NZ$000

NZ$000

NZ$000

Opening balance

698



1,437



-



Acquisition of subsidiaries

-



-



1,437



Current period beekeeping costs

1,334



3,949



7,239



Impairment of biological work in progress asset

(861)



-



-



Fair value loss on harvested honey

-



-



(1,724)



Honey recognised as inventory on harvest

-



-



(6,952)



Beekeeping costs related to next harvest

-



-



698



At reporting date

1,171



5,386



698



Premises Hive

placements

Total

NZ$000NZ$000NZ$000

Cost:

At 1 July 20211,160 1,071 2,231

Additions296 313 609

At 31 December 20211,456 1,384 2,840

Lease modifications*(82) (626) (708)

At 30 June 20221,374 758 2,132

Additions- 186 186

Lease modifications*(294) (224) (518)

At 31 December 20221,080 720 1,800

Accumulated amortisation:

At 1 July 2021(69) - (69)

Depreciation expense(175) (283) (458)

At 31 December 2021(244) (283) (527)

Depreciation expense(177) (41) (218)

At 30 June 2022(421) (324) (745)

Depreciation expense(172) (82) (254)

At 31 December 2022

(593) (406) (999)

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



14



* Lease modifications – the Group has reassessed the likely period of renewal of leases impacted by the

Board’s decision to downsize its beekeeping operations and adjusted the related right-of-use assets and

lease liabilities accordingly.


12.2. Lease liability



Short term lease expenses included in operating loss were $309,234 (2021: $528,607).

13. Borrowings


The Group’s bank has provided a principal repayment holiday through to 31 August 2023. The

subordinated note is repayable in June 2024.

Premises

Hive

placements

Total

NZ$000

NZ$000

NZ$000

Carrying amounts:

At 31 December 2022

487



314



801



At 30 June 2022

953



434



1,387



At 31 December 2021

1,212



1,101



2,313



At 1 July 2021

1,091



1,071



2,162



31 Dec 2022

30 Jun 2022

(unaudited)

(audited)

NZ$000

NZ$000

Maturity analysis - contractual undiscounted cash flows

Up to one year

413

381

One to two years

258

526

Two to five years

155

492

More than five years

-

77

Total undiscounted lease liabilities at period end

826

1,476

Lease liabilities included in the statement of financial position at balance date

Current

281

316

Non-current

501

1,041

782

1,357

31 Dec 202230 Jun 2022

(unaudited)(audited)

NZ$000NZ$000

Banks loans7,0347,034

Subordinated note5,3005,200

12,33412,234

Current538942

Non-current11,79611,292

12,33412,234

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



15

14. Related parties

14.1. Directors

The names of persons who are directors of the Company are; Grant Baker (Chairman), Hannah Barrett,

Roger Gower, Michael Kerr, Richard Pearson, Stephen Sinclair and Antony Vriens.

14.2. Key management personnel compensation

Key management personnel compensation is set out below. The key management personnel are all the

directors of the Company.

Directors were paid directors’ fees of $235,000 in the 6 months to 31 December 2022 (6 months to 31

December 2021: $197,500). $45,437 was payable to directors at 31 December 2022 (30 June 2022:

$14,062). The $45,437 is payable to the independent directors and is intended to be settled by the issue

of shares in the Company (30 June 2022: $14,062).

Michael Kerr received total remuneration of $125,000 in the current period in his role as CEO (6 months to

31 December 2021: $112,500).

A company owned by Stephen Sinclair received $62,500 in consulting fees (6 months to 31 December

2021: $62,500).

14.3. Related entities

MTL Securities Limited is an entity owned and controlled by M & N Kerr Holdings, of which Michael Kerr is

a director, and Velocity Capital, of which Grant Baker and Stephen Sinclair are directors. MTL Securities

Limited owns 44.86% of Me Today Limited.

14.4. Related party transactions

On 15 June 2020 the Company entered into an Ambassador Agreement with BB Promotions Limited for a

term of three years. BB Promotions Limited is a related party to the Group, as the shareholder and director

of BB Promotions Limited, B Barrett, is married to H Barrett, a director of the Company. Under the terms of

the agreement, BB Promotions Limited agreed to provide promotional services to the Company in

exchange for the payment of $50,000 per annum, the issue by the Company of ordinary shares to BB

Promotions Limited to the value of $100,000 per annum, and the granting of 3,000,000 options to

purchase ordinary shares in the Company. 1,000,000 share options remained on issue at the reporting

date (30 June 2022: 1,000,000). Share based payments for promotion services in the period was $53,000

(6 months to 31 December 2021: $62,000) in relation to the Ambassador Agreement with BB Promotions

Limited.

Hannah Barrett received $6,250 for providing marketing services to the Group (6 months to 31 December

2021: $7,500).

14.5. Share placement subscription agreement (2021)

On 26 November 2021, Me Today, the TW Jarvis (No. 1) Family Trust (“Jarvis Trust”) and MTL Securities

Limited entered into a share placement subscription agreement under which the Jarvis Trust and MTL

Securities Limited agreed to invest additional cash of $6 million through a share placement, conditional

upon shareholder approval. The shares were issued at 8.8 cents per share, the same issue price for

capital raised as part of the King Honey acquisition and reflecting their respective shareholdings. MTL

Securities Limited agreed to contribute $3.75 million and Jarvis Trust $2.25 million. Shareholders

approved the share placement on 18 March 2022.

Jarvis Trust is a substantial security holder in Me Today and is the previous vendor of King Honey Limited.

MTL Securities Limited is a substantial security holder, and the largest shareholder, in Me Today. MTL

Securities Limited is an entity owned and controlled by M & N Kerr Holdings, of which Michael Kerr is a

director, and Velocity Capital, of which Grant Baker and Stephen Sinclair are directors.

Me Today Limited
Condensed Notes to the Interim Consolidated Financial Statements

For the six months ended 31 December 2022



16

15. Reconciliation of loss after taxation with cash flow from operating activities



16. Contingent liabilities

There are no contingent liabilities as at 31 December 2022 (30 June 2022: nil).

17. Commitments

The Company had no commitments for future capital expenditure as at 31 December 2022 (30 June 2022:

nil).

18. Events subsequent to reporting date

There have been no significant events after the reporting date.


6 mths ended

6 mths ended

31 Dec 2022

31 Dec 2021

(unaudited)

(unaudited)

NZ$000

NZ$000

Net loss after taxation

(5,805)

(3,905)

Adjustments for:

Depreciation and amortisation

557

910

Amortisation of customer relationship asset

542

542

Share-based payments

64

68

Interest paid on lease liabilities

19

43

Interest paid on borrowings

277

259

Impairment of biological work in progress asset

861

-

Fair value loss on biological assets

544

-

Write down of assets held for sale

98

-

Acquisition related costs

-

45

Movements in working capital

(Increase) / decrease in trade and other receivables

(1,653)

(839)

(Increase) / decrease in inventory

1,145

506

(Increase) / decrease in biological work in progress

(1,334)

(3,979)

Increase / (decrease) in trade and other payables

19

309

(Increase) / decrease in taxation receivable

26

(4)

Net cash outflows from operating activities

(4,640)

(6,045)

Me Today Limited
Company Directory

As at 31 December 2022




17


Registered Office

Level 1, 25 Broadway

Newmarket

Auckland

New Zealand


Postal Address

PO Box 109047

Newmarket

Auckland 1023


Bankers

BNZ

Deloitte Building

80 Queen Street

Auckland 1010

New Zealand


Lawyers

Chapman Tripp

Level 34, PwC Tower

15 Customs Street West

Auckland 1010

New Zealand


Auditor

BDO Auckland

4 Graham Street

Auckland

New Zealand


Share Registry

Computershare Investor Services Limited

Level 2, 159 Hurstmere Road

Takapuna

Auckland


PO Box 92119

Auckland 1142

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • CVT — Comvita Limited: Record First Half Earnings at Comvita
    2023-02-22

    C O M V I T A I N V E S T O R P R E S E N T A T I O N H A L F Y E A R R E S U L T F Y 2 3 Climate action performance S U S T A I N A B I L I T Y F Y 2 3 H A L F Y E A R 774T CO 2 e GHG H1 INVENTORY SCOPES 1 & 2 2022 H1: 652 T CO2e +19% 4,748T CO 2 e CARBON REMOVA…”

  • CVT — Comvita Limited: Trading update – Honey harvest and forecast market demand
    2023-05-01

    2 May 2023 Trading update – Honey harvest and forecast market demand Comvita Limited (NZX: CVT) global market leader in Mānuka honey, Propolis and Fresh-Picked™ Olive Leaf Extract is pleased to maintain guidance of double-digit EBITDA growth (after one-off ERP costs previously…”

  • NZM — NZME Limited: NZME Full Year Results to 31 December 2022
    2023-02-21

    NZME Limited. 2-4 Graham Street, Private Bag 92198, Victoria Street West, Auckland. 2 MARKET ANNOUNCEMENT OneRoof has also grown its audience to 564,000 6 and has 89% of residential for sale listings nationwide 7 , continuing to close the gap with its closest competitor.…”